Sun Pharma Inds. - Quaterly Results
Date: 29-07-2022
A decent increase of about 34.58% in the sales to Rs. 49328.80 millions was observed for the quarter ended June 2022. The sales figure stood at Rs. 36652.90 millions during the year-ago period.The Total Profit for the quarter ended June 2022 of Rs. 10118.00 millions grew from Rs.-1382.80 millionsOperating Profit saw a handsome growth to 14986.50 millions from 4550.30 millions in the quarter ended June 2022.
| | Quarter ended | Year to Date | Year ended |
| | 202206 | 202106 | % Var | 202206 | 202106 | % Var | 202203 | 202103 | % Var |
| Sales | 49328.80 | 36652.90 | 34.58 | 49328.80 | 36652.90 | 34.58 | 155859.80 | 141160.50 | 10.41 |
| Other Income | 1762.10 | 2116.90 | -16.76 | 1762.10 | 2116.90 | -16.76 | 11968.80 | 1920.70 | 523.15 |
| PBIDT | 14986.50 | 4550.30 | 229.35 | 14986.50 | 4550.30 | 229.35 | 38654.40 | 24490.80 | 57.83 |
| Interest | 870.70 | 1074.60 | -18.97 | 870.70 | 1074.60 | -18.97 | 3881.00 | 2675.20 | 45.07 |
| PBDT | 14115.80 | 1820.00 | 675.59 | 14115.80 | 1820.00 | 675.59 | 16568.10 | 20920.00 | -20.80 |
| Depreciation | 3745.00 | 3069.30 | 22.01 | 3745.00 | 3069.30 | 22.01 | 13499.50 | 12364.30 | 9.18 |
| PBT | 10370.80 | -1249.30 | -930.13 | 10370.80 | -1249.30 | -930.13 | 3068.60 | 8555.70 | -64.13 |
| TAX | 252.80 | 133.50 | 89.36 | 252.80 | 133.50 | 89.36 | 4068.50 | 131.70 | 2989.22 |
| Deferred Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PAT | 10118.00 | -1382.80 | -831.70 | 10118.00 | -1382.80 | -831.70 | -999.90 | 8424.00 | -111.87 |
| Equity | 2399.30 | 2399.30 | 0.00 | 2399.30 | 2399.30 | 0.00 | 2399.30 | 2399.30 | 0.00 |
| PBIDTM(%) | 30.38 | 12.41 | 144.72 | 30.38 | 12.41 | 144.72 | 24.80 | 17.35 | 42.95 |